Latest News

Declines in the death rate for breast cancer have furthered overall progress in cancer mortality.

Marcella Nunez-Smith is laser-focused on eliminating inequities among marginalized people.

Today, Explained [a podcast] digs into the stigma associated with prostate cancer diagnosis like Defense Secretary Lloyd Austin’s, and the fear many men have of the exam itself.

Michael Leapman, MD, MHS, shares background and key findings from the study, “Temporal and regional patterns of prostate cancer positron emission tomography imaging among commercial insurance beneficiaries in the United States.”

New research illustrates remarkably lower use of immediate breast reconstruction in older women of Asian descent.

In a Q&A, Ilana Richman, MD, MHS, assistant professor of medicine (general medicine), discusses why overdiagnosis is a concern, the challenges of assessing the benefit of new screening technologies, and the risks and benefits people should weigh when considering preventative screening.

Henry S. Park, MD, MPH, participates in a Q&A for Lung Cancer Awareness Month.

Are you eligible for lung cancer screening? Earlier this week, the American Cancer Society (ACS) released updated lung cancer screening guidelines that will allow more than 5 million additional U.S. adults who smoke and formerly smoked to get screened for lung cancer. Typically, screening finds the early stage cancers while the later-stage cancers are found when people have symptoms, Daniel Boffa, MD, division chief of thoracic surgery and clinical director of the Center for Thoracic Cancers at Yale Cancer Center and Smilow Cancer Hospital told Health. “Screening works by finding dangerous cancers before they do dangerous things,” he said. “Overall people that participate in lung cancer screening reduce their chances of dying of lung cancer by 20%.”

October was Breast Cancer Awareness month and the sudden influx of pink in our homes, on our televisions, in our workplaces, and in local businesses reminded us that we still lose far too many of our loved ones to cancer, not only in this form but in so many others. While the race to discover new diagnostics and treatments remains imperative, there is another pressing issue emerging for patients with cancer. With advances in early detection, treatment, and oncologic outcomes, many individuals diagnosed with cancer are now living longer and are thus more likely to die from or develop conditions other than cancer. Two thirds of all individuals diagnosed with cancer now live 5 years or more past diagnosis, and the number of such "long-term" survivors in the U.S. will rise from 15.5 million to 20 million by 2026. As such, there is a pressing need to encourage the shift in survivorship care away from oncologists back to primary care physicians and other non-oncologists.